Answers are grounded in this paper and cite their sources.
Background: Fournier’s gangrene is a life-threatening necrotizing fasciitis with mortality rates of 20%–50%. Early identification of high-risk patients is essential, yet practical prognostic tools derived from routine laboratory tests remain limited. Aim: To compare seven prognostic indices and develop a novel procalcitonin-based index (PCT-ALLY) for mortality prediction in patients with Fournier’s gangrene. Methods: In this single-center retrospective cohort, 220 surgically treated patients (January 2007–September 2025) were evaluated. Preoperative laboratory data were used to calculate neutrophil–to–lymphocyte ratio (NLR), platelet–to–lymphocyte ratio, hemoglobin–albumin–lymphocyte–platelet (HALP), prognostic nutritional index, systemic inflammation response index (SIRI), C–reactive protein–albumin–lymphocyte (CALLY), and the newly developed PCT-ALLY. The primary endpoint was 30-day or in-hospital mortality. Discrimination was assessed using receiver operating characteristic analysis with DeLong testing and multivariable logistic regression. Results: Mortality occurred in 66 patients (30%). CALLY showed the highest area under the curve (0.935; 95% confidence interval [CI] 0.890–0.965), followed by PCT-ALLY (0.874; 95% CI 0.821–0.916). PCT-ALLY had the highest specificity (87.0%) and outperformed NLR ( P = 0.032) and SIRI ( P = 0.045). In multivariable analysis, CALLY (odds ratio [OR] 7.210; P < 0.001), HALP (OR 3.816; P < 0.001), and PCT-ALLY (OR 3.649; P < 0.001) were independent predictors of mortality. Conclusions: Immuno-nutritional indices, particularly CALLY and PCT-ALLY, provide strong, easily calculable, and cost-effective mortality prediction in Fournier’s gangrene and may support early risk stratification. Prospective multicenter validation is warranted.
No takes yet. Share an insight, caveat, or question.
Sesli et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: